Search research articles
Contact Us
Filters
Showing results (121-130 of 144) with videos related to
Page
of 15
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 25, 2018
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
Tanya Simuni, Andrew Siderowf, Shirley Lasch, et al.
The Lancet. Neurology
|
November 4, 2019
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Tanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, et al.
Annals of Neurology
|
July 11, 2025
Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder
Daniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 17, 2020
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
Brit Mollenhauer, Mohammed Dakna, Niels Kruse, et al.
Clinical Pharmacology and Therapeutics
|
April 24, 2021
A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 Mutation
Malidi Ahamadi, Nitin Mehrotra, Nathan Hanan, et al.
Annals of Clinical and Translational Neurology
|
December 20, 2018
The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort
Kenneth Marek, Sohini Chowdhury, Andrew Siderowf, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 20, 2020
Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study
Tanya Simuni, Michael C Brumm, Liz Uribe, et al.
Annals of Neurology
|
May 11, 2026
Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease
Andrew Siderowf, Laura E A Heathers, Kimberly Fabrizio, et al.
Neurology
|
February 2, 2024
Evaluation of ATN<sub>PD</sub> Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease
Katheryn A Q Cousins, David J Irwin, Thomas F Tropea, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 27, 2018
Movement disorder society criteria for clinically established early Parkinson's disease
Daniela Berg, Charles H Adler, Bastiaan R Bloem, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 144) with videos related to
Sort By:
Page
of 15
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 25, 2018
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
Tanya Simuni, Andrew Siderowf, Shirley Lasch, et al.
The Lancet. Neurology
|
November 4, 2019
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Tanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, et al.
Annals of Neurology
|
July 11, 2025
Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder
Daniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 17, 2020
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
Brit Mollenhauer, Mohammed Dakna, Niels Kruse, et al.
Clinical Pharmacology and Therapeutics
|
April 24, 2021
A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 Mutation
Malidi Ahamadi, Nitin Mehrotra, Nathan Hanan, et al.
Annals of Clinical and Translational Neurology
|
December 20, 2018
The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort
Kenneth Marek, Sohini Chowdhury, Andrew Siderowf, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 20, 2020
Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study
Tanya Simuni, Michael C Brumm, Liz Uribe, et al.
Annals of Neurology
|
May 11, 2026
Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease
Andrew Siderowf, Laura E A Heathers, Kimberly Fabrizio, et al.
Neurology
|
February 2, 2024
Evaluation of ATN<sub>PD</sub> Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease
Katheryn A Q Cousins, David J Irwin, Thomas F Tropea, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 27, 2018
Movement disorder society criteria for clinically established early Parkinson's disease
Daniela Berg, Charles H Adler, Bastiaan R Bloem, et al.
Page
of 15